Dec 12, 2022 7:00am EST Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group
Dec 06, 2022 8:00am EST Pasithea Therapeutics to Present at Annual Meeting of the Antibody Society Conference
Nov 28, 2022 7:05pm EST Pasithea Therapeutics Postpones Special Meeting until December 9, 2022 at 9:00 AM Eastern Time
Oct 17, 2022 8:00am EDT Pasithea Therapeutics to Present Tolerizing Vaccine Program Results at Immunotherapy 2022 International Course and Symposium
Sep 20, 2022 8:00am EDT Pasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of Directors
Sep 15, 2022 8:00am EDT Pasithea Therapeutics Further Strengthens its Scientific Advisory Board with the Appointment of Dr. Merit Cudkowicz
Sep 09, 2022 10:32am EDT Pasithea Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Aug 18, 2022 8:00am EDT Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference
